Insmed Incorporated
INSM
$72.65
$2.453.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -235.55M | -220.52M | -300.61M | -157.09M | -186.06M |
| Total Depreciation and Amortization | 2.21M | 2.19M | 2.16M | 2.32M | 2.20M |
| Total Amortization of Deferred Charges | 2.96M | 2.70M | 3.01M | 3.06M | 2.96M |
| Total Other Non-Cash Items | 6.28M | 50.45M | 132.92M | 22.81M | 42.40M |
| Change in Net Operating Assets | 28.12M | -15.73M | 39.56M | -55.13M | 7.67M |
| Cash from Operations | -195.98M | -180.92M | -122.95M | -184.04M | -130.82M |
| Capital Expenditure | -6.77M | -3.69M | -6.78M | -4.68M | -2.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 138.53M | -999.78M | 0.00 | 300.00M | 3.96M |
| Cash from Investing | 131.76M | -1.00B | -6.78M | 295.32M | 1.80M |
| Total Debt Issued | 150.00M | -- | -- | -- | -- |
| Total Debt Repaid | -686.00K | -658.00K | -645.00K | -621.00K | 1.17M |
| Issuance of Common Stock | 13.73M | 397.86M | 781.73M | 4.05M | 122.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.74M | -- | 409.00K | -409.00K | 0.00 |
| Cash from Financing | 159.31M | 397.20M | 781.49M | 3.02M | 123.26M |
| Foreign Exchange rate Adjustments | -1.51M | 1.84M | -688.00K | -953.00K | 1.01M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.58M | -785.35M | 651.07M | 113.36M | -4.74M |